. 2022 Dec;11(12):1908–1923. doi: 10.21037/gs-22-701

Table 3. Relationship between the BRAF^V600E mutation and PD-L1 expression in 137 patients with early PTC.

Expressing Status	PD-L1 expression			OR value	OR, 95% CI	P value
Expressing Status	+	−	Total	OR value	OR, 95% CI	P value
BRAF^V600E mutation
+	40	16	56	3.125	(1.511, 6.464)	0.002
−	36	45	81
Total	76	61	137

PD-L1, programmed death-ligand 1; PTC, papillary thyroid carcinoma; OR, odds ratio; CI, confidence interval.

Table 3. Relationship between the BRAFV600E mutation and PD-L1 expression in 137 patients with early PTC.